share_log

Aurora Cannabis Inc. (NYSE:ACB) Given Consensus Rating of "Hold" by Brokerages

Aurora Cannabis Inc. (NYSE:ACB) Given Consensus Rating of "Hold" by Brokerages

Aurora Cannabis Inc.(紐約證券交易所代碼：ACB)被券商一致評級為持有
Defense World ·  2022/09/25 03:21

Shares of Aurora Cannabis Inc. (NYSE:ACB – Get Rating) have been assigned a consensus recommendation of "Hold" from the eleven analysts that are covering the company, Marketbeat.com reports. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating and one has issued a buy rating on the company. The average 12 month target price among brokerages that have issued a report on the stock in the last year is $4.38.

據Marketbeat.com報道，Aurora Cannabis Inc.(紐約證券交易所代碼：ACB-GET Rating)的股票已被跟蹤該公司的11位分析師一致建議持有。兩名股票研究分析師對該股的評級為賣出，七名分析師給出了持有評級，一名分析師對該公司發出了買入評級。在過去一年發佈該股報告的券商中，12個月目標價的平均水平為4.38美元。

Several research analysts recently issued reports on the company. Stifel Nicolaus raised Aurora Cannabis from a "sell" rating to a "hold" rating and set a $2.15 target price on the stock in a research report on Monday, June 6th. Atb Cap Markets raised Aurora Cannabis from an "underperform" rating to a "sector perform" rating in a research report on Thursday. Canaccord Genuity Group raised Aurora Cannabis from a "sell" rating to a "hold" rating in a research report on Wednesday. Cantor Fitzgerald raised Aurora Cannabis from a "neutral" rating to an "overweight" rating in a research report on Friday, June 24th. Finally, Piper Sandler reduced their target price on Aurora Cannabis from $4.00 to $3.00 and set a "neutral" rating on the stock in a research report on Wednesday.

幾位研究分析師最近發佈了關於該公司的報告。Stifel Nicolaus在6月6日週一的一份研究報告中將Aurora Cannabis的評級從“賣出”上調至“持有”，併為該股設定了2.15美元的目標價。ATB Cap Markets在週四的一份研究報告中將Aurora Cannabis的評級從“表現不佳”上調至“行業表現”。在週三的一份研究報告中，Canaccel Genuity Group將Aurora Cannabis的評級從“賣出”上調至“持有”。坎託·菲茨傑拉德在6月24日星期五的一份研究報告中將奧羅拉大麻的評級從中性上調至增持。最後，派珀·桑德勒在週三的一份研究報告中將其對Aurora Cannabis的目標價從4.00美元下調至3.00美元，並將該股的評級定為“中性”。

Get
到達
Aurora Cannabis
極光大麻
alerts:
警報：

Aurora Cannabis Trading Down 1.6 %

奧羅拉大麻交易下跌1.6%

Shares of NYSE ACB opened at $1.20 on Friday. The company has a debt-to-equity ratio of 0.36, a current ratio of 5.13 and a quick ratio of 4.76. The stock has a market capitalization of $272.16 million, a P/E ratio of -0.20 and a beta of 2.64. Aurora Cannabis has a 1-year low of $1.12 and a 1-year high of $8.69. The business has a fifty day moving average price of $1.52 and a 200 day moving average price of $2.20.

上週五，紐約證交所ACB的股價開盤報1.20美元。該公司的債務權益比為0.36，流動比率為5.13，速動比率為4.76。該股市值為2.7216億美元，市盈率為-0.20，貝塔係數為2.64。Aurora Cannabis的一年低點為1.12美元，一年高位為8.69美元。該業務的50日移動平均價為1.52美元，200日移動平均價為2.20美元。

Institutional Inflows and Outflows

機構資金流入和流出

A number of hedge funds have recently modified their holdings of ACB. Dimensional Fund Advisors LP grew its holdings in Aurora Cannabis by 78.0% during the fourth quarter. Dimensional Fund Advisors LP now owns 667,099 shares of the company's stock worth $3,609,000 after acquiring an additional 292,222 shares during the period. Seven Eight Capital LP grew its holdings in Aurora Cannabis by 25.1% during the fourth quarter. Seven Eight Capital LP now owns 337,344 shares of the company's stock worth $1,825,000 after acquiring an additional 67,621 shares during the period. Gotham Asset Management LLC acquired a new stake in Aurora Cannabis during the fourth quarter worth about $64,000. F3Logic LLC grew its holdings in Aurora Cannabis by 104.3% during the first quarter. F3Logic LLC now owns 41,920 shares of the company's stock worth $167,000 after acquiring an additional 21,400 shares during the period. Finally, Mirae Asset Global Investments Co. Ltd. grew its holdings in Aurora Cannabis by 2.7% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 1,615,895 shares of the company's stock worth $6,464,000 after acquiring an additional 42,423 shares during the period. 29.53% of the stock is owned by institutional investors and hedge funds.
多家對衝基金最近調整了對ACB的持股。Dimension Fund Advisors LP在第四季度增持了78.0%的Aurora Cannabis。Dimension Fund Advisors LP在此期間額外收購了292,222股，目前擁有該公司667,099股股票，價值3,609,000美元。七八資本有限責任公司在第四季度增持了25.1%的Aurora Cannabis。在此期間增持了67,621股後，SEVEN Eight Capital LP現在擁有337,344股該公司的股票，價值1,825,000美元。Gotham Asset Management LLC在第四季度收購了Aurora Cannabis的新股份，價值約6.4萬美元。F3Logic LLC在第一季度增持了104.3%的Aurora Cannabis。F3Logic LLC在此期間額外收購了21,400股票，現在擁有41,920股該公司股票，價值167,000美元。最後，未來資產全球投資有限公司在第一季度增持了2.7%的奧羅拉大麻。未來資產全球投資有限公司在此期間增持了42,423股後，目前持有1,615,895股該公司股票，價值6,464,000美元。29.53%的股票由機構投資者和對衝基金持有。

Aurora Cannabis Company Profile

奧羅拉大麻公司簡介

(Get Rating)

(獲取評級)

Aurora Cannabis Inc produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients.

Aurora Cannabis Inc.在加拿大和國際上生產、分銷和銷售大麻和大麻衍生產品。它還從事設施工程和設計、大麻育種、研究、生產、衍生品、產品開發、批發和零售分銷活動。該公司生產各種類型的幹大麻、大麻油和膠囊，以及供內科患者使用的外用藥包。

Further Reading

進一步閲讀

  • Get a free copy of the StockNews.com research report on Aurora Cannabis (ACB)
  • Will Wall Street's Enthusiasm About Datadog Lead To Big Gains?
  • MarketBeat: Week in Review 9/19 – 9/23
  • Why Does Tesla Stock Remain Resilient?
  • Is Costco's Post-Earnings Price Weakness A Good Time To Buy?
  • Are Layoffs At A Small-Cap Tech A Bellwether For Housing Stocks?
  • 免費獲取StockNews.com關於Aurora Cannabis(ACB)的研究報告
  • 華爾街對Datadog的熱情會帶來巨大的收益嗎？
  • MarketBeat：回顧一週9/19-9/23
  • 為什麼特斯拉的股票保持彈性？
  • 好市多盈利後價格疲軟是買入的好時機嗎？
  • 小盤股的裁員是樓市的晴雨表嗎？

Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.

接受《奧羅拉大麻日報》的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對Aurora Cannabis和相關公司的最新新聞和分析師評級的每日簡要摘要。

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論